Microbix Biosystems Inc T.MBX

Alternate Symbol(s): MBXBF

Healthcare Biotechnology

Microbix Biosystems Inc. develops and commercializes biological and technological solutions for human health and wellbeing. It enables the commercialization of diagnostic assays by making a range of critical ingredients and devices for the global diagnostics industry, notably antigens for immunoassays and its laboratory quality assessment products (QAPs) that support clinical lab proficiency testing, enable assay development and validation, or help ensure the quality of clinical diagnostic workflows. Its segments include development, manufacturing and sales of products relating to the medical diagnostics industry, namely antigens as test ingredients, quality assessment products to help ensure the accuracy of test workflows and viral transport medium to enable collection of patient test samples and, and development and commercialization of novel and proprietary products or technologies, such as Kinlytic. Its Kinlytic urokinase is a biologic thrombolytic drug used to treat blood clots.

TSX:MBX - Post by User

Microbix Biosystems Inc

<< Previous

Bullboard Posts

Next >>

Post by wizzdumbon Dec 22, 2021 4:08pm

166 Views

Post# 34255975

Nice Close and Good Luck

Nice volume and appreciation in last few days. Looking forward to tomorrow mornings numbers and management comments. Fingers crossed that we close out this year on a great note as 2022 is looking to be the best year for MBX in its long history.

<< Previous

Bullboard Posts

Next >>

FE Battery Metals begins 2024 winter drill program